$5.9 million

A minor child was admitted to the hospital for treatment of a severe asthma attack…Full Story

$5 million

For a 20-year-old former cheerleader and high achiever…Full Story

$4.809 million

A 44-year-old woman was stopped at an intersection when struck by a dump truck at 40 mph…Full Story

Learn More

• About the Firm
• Auto Accidents
• Nursing Homes
• Workers' Compensation
• Medical Malpractice
• Premises Liability About the Firm
• Semi-Trucks
• Community Involvement

Heart Surgery Drug Causes Kidney Failure and Death

With more than 22,000 lives lost over the use of the drug Trasylol- drug maker Bayer would like to bring it back to the market. Used to reduce bleeding during open heart surgery, Trasylol was the subject of a recent 60 Minutes report.

It showed that Bayer AG withheld vital yet negative information about the incidents of kidney failure requiring dialysis, heart attack, stroke and death among patients on Trasylol from an FDA panel looking at the drug’s safety.  FDA advisory panel chair Dr.William Hiatt said that had he known about the number of deaths from Trasylol, he would not have voted to keep the drug on the market in 2006.

In January, 2006, the New England Journal of Medicine reported that in more than 4,000 coronary bypass artery graft patients given Trasylol suffered twice the risk of renal (kidney) failure and stroke and had a 55% increase in the occurrences of heart failure or heart attack.

By October 2007, so many Canadian patients were drying that a study involving Trasylol had to be suspended.  One month later Bayer initiated a “temporary marketing suspension.”  However, Trasylol is still available to doctors who claim they must use it for especially sensitive heart surgeries.

As many as one-third of heart surgery patients received the drug during the height of its 14 years on the market after an aggressive, negligent and deceptive marketing campaign.

Dr. Dennis Mangano, an independent medical researcher warned the FDA about Trasylol in January 2006, yet the FDA decided to keep the drug on the market. Dr. Mangano says that had the FDA paid attention to his warning— 22,000 lives could have been saved— that’s 1,000 lives a month.

If you or a loved one has experienced kidney failure after heart surgery, complications, heart attack or stroke, you may have received Trasylol in the hospital unknowingly.   You need to contact a compassionate and knowledgeable defective drug attorney today to help evaluate your case thoroughly before the statute of limitations runs out.